208 related articles for article (PubMed ID: 1703070)
1. Modulation of mediator release from human intestinal mast cells by sulfasalazine and 5-aminosalicylic acid.
Fox CC; Moore WC; Lichtenstein LM
Dig Dis Sci; 1991 Feb; 36(2):179-84. PubMed ID: 1703070
[TBL] [Abstract][Full Text] [Related]
2. Differential modulation of mediator release from human basophils and mast cells by mizolastine.
Triggiani M; Giannattasio G; Balestrieri B; Granata F; Gelb MH; de Paulis A; Marone G
Clin Exp Allergy; 2004 Feb; 34(2):241-9. PubMed ID: 14987304
[TBL] [Abstract][Full Text] [Related]
3. Contrast media are incomplete secretagogues acting on human basophils and mast cells isolated from heart and lung, but not skin tissue.
Genovese A; Stellato C; Patella V; Lamparter-Schummert B; de Crescenzo G; Adt M; Marone G
Int J Clin Lab Res; 1996; 26(3):192-8. PubMed ID: 8905451
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory effects of sulfasalazine and its metabolites on histamine release and TNF-alpha production by mast cells.
Bissonnette EY; Enciso JA; Befus AD
J Immunol; 1996 Jan; 156(1):218-23. PubMed ID: 8598465
[TBL] [Abstract][Full Text] [Related]
5. The human recombinant c-kit receptor ligand, rhSCF, induces mediator release from human cutaneous mast cells and enhances IgE-dependent mediator release from both skin mast cells and peripheral blood basophils.
Columbo M; Horowitz EM; Botana LM; MacGlashan DW; Bochner BS; Gillis S; Zsebo KM; Galli SJ; Lichtenstein LM
J Immunol; 1992 Jul; 149(2):599-608. PubMed ID: 1378071
[TBL] [Abstract][Full Text] [Related]
6. Enhanced formation of sulfidopeptide-leukotrienes in ulcerative colitis and Crohn's disease: inhibition by sulfasalazine and 5-aminosalicylic acid.
Peskar BM; Dreyling KW; Peskar BA; May B; Goebell H
Agents Actions; 1986 Jun; 18(3-4):381-3. PubMed ID: 2875632
[TBL] [Abstract][Full Text] [Related]
7. Intestinal mast cell responses in idiopathic inflammatory bowel disease. Histamine release from human intestinal mast cells in response to gut epithelial proteins.
Fox CC; Lichtenstein LM; Roche JK
Dig Dis Sci; 1993 Jun; 38(6):1105-12. PubMed ID: 7685262
[TBL] [Abstract][Full Text] [Related]
8. Modulation of the release of histamine and arachidonic acid metabolites from human basophils and mast cells by auranofin.
Marone G; Columbo M; Galeone D; Guidi G; Kagey-Sobotka A; Lichtenstein LM
Agents Actions; 1986 Apr; 18(1-2):100-2. PubMed ID: 2425566
[TBL] [Abstract][Full Text] [Related]
9. Histamine release from gut mast cells from patients with inflammatory bowel diseases.
Nolte H; Spjeldnaes N; Kruse A; Windelborg B
Gut; 1990 Jul; 31(7):791-4. PubMed ID: 1695160
[TBL] [Abstract][Full Text] [Related]
10. Nimesulide, a sulfonanilide nonsteroidal anti-inflammatory drug, inhibits mediator release from human basophils and mast cells.
Casolaro V; Meliota S; Marino O; Patella V; de Paulis A; Guidi G; Marone G
J Pharmacol Exp Ther; 1993 Dec; 267(3):1375-85. PubMed ID: 7505332
[TBL] [Abstract][Full Text] [Related]
11. Disassociation of the release of histamine and arachidonic acid metabolites from osmotically activated basophils and human lung mast cells.
Eggleston PA; Kagey-Sobotka A; Proud D; Adkinson NF; Lichtenstein LM
Am Rev Respir Dis; 1990 Apr; 141(4 Pt 1):960-4. PubMed ID: 1691604
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of human intestinal mast cell mediator release in active ulcerative colitis.
Fox CC; Lazenby AJ; Moore WC; Yardley JH; Bayless TM; Lichtenstein LM
Gastroenterology; 1990 Jul; 99(1):119-24. PubMed ID: 1693122
[TBL] [Abstract][Full Text] [Related]
13. The pharmacologic control of mediator release from human basophils and mast cells.
Peters SP; Naclerio RM; Schleimer RP; MacGlashan DW; Pipkorn U; Lichtenstein LM
Respiration; 1986; 50 Suppl 2():116-22. PubMed ID: 3494282
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of histamine and prostaglandin D2 release from human lung mast cells by ciclosporin A.
Triggiani M; Cirillo R; Lichtenstein LM; Marone G
Int Arch Allergy Appl Immunol; 1989; 88(1-2):253-5. PubMed ID: 2468619
[TBL] [Abstract][Full Text] [Related]
15. The effect of 5-aminosalicylic acid-containing drugs on sulfide production by sulfate-reducing and amino acid-fermenting bacteria.
Edmond LM; Hopkins MJ; Magee EA; Cummings JH
Inflamm Bowel Dis; 2003 Jan; 9(1):10-7. PubMed ID: 12656132
[TBL] [Abstract][Full Text] [Related]
16. Effect of lidocaine on histamine release and Ca2+ mobilization from mast cells and basophils.
Yanagi H; Sankawa H; Saito H; Iikura Y
Acta Anaesthesiol Scand; 1996 Oct; 40(9):1138-44. PubMed ID: 8933856
[TBL] [Abstract][Full Text] [Related]
17. Modulation of rat peritoneal mast cell and human basophil histamine release by estrogens.
Cocchiara R; Albeggiani G; Di Trapani G; Azzolina A; Lampiasi N; Rizzo F; Geraci D
Int Arch Allergy Appl Immunol; 1990; 93(2-3):192-7. PubMed ID: 1712002
[TBL] [Abstract][Full Text] [Related]
18. In vitro effects of H1-antihistamines on histamine and PGD2 release from mast cells of human lung, tonsil, and skin.
Okayama Y; Benyon RC; Lowman MA; Church MK
Allergy; 1994 Apr; 49(4):246-53. PubMed ID: 7518654
[TBL] [Abstract][Full Text] [Related]
19. Heterogeneous effects of protamine on human mast cells and basophils.
Patella V; Ciccarelli A; Lamparter-Schummert B; de Paulis A; Adt M; Marone G
Br J Anaesth; 1997 Jun; 78(6):724-30. PubMed ID: 9215027
[TBL] [Abstract][Full Text] [Related]
20. Human basophil/mast cell releasability. VII. Heterogeneity of the effect of adenosine on mediator secretion.
Marone G; Cirillo R; Genovese A; Marino O; Quattrin S
Life Sci; 1989; 45(19):1745-54. PubMed ID: 2480501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
